Archives of Neurology · 2002 · 157 citations · 33 references
MedicineNeurologyNeuroscienceCognitive NeurologyDementiaNeurodegenerationAlzheimer DiseaseCerebrovascular DiseaseDementia BiomarkersDementia EpidemiologyDementia Risk FactorsStrokeAlzheimer Disease EpidemiologyHomocysteine ElevationWhite Matter AbnormalitiesWhite Matter ImagingWhite Matter Involvement
CONTEXT: The pathogenesis of leukoaraiosis on computed tomographic (CT) scanning is unknown, but cerebrovascular risk factors for leukoaraiosis show overlap with those for Alzheimer disease (AD). OBJECTIVE: To investigate the contribution of cerebrovascular risk factors, in particular plasma total homocysteine (tHcy), to leukoaraiosis in patients with AD and controls. DESIGN: Cross-sectional case-control study. SETTING: Referral population to a hospital clinic and community volunteers from the Oxfordshire region in England seen between July 1, 1988, and July 1, 2000. PARTICIPANTS: One hundred thirty-seven AD cases (104 confirmed post mortem) and 277 controls matched for age (mean +/- SD, 73 +/- 8 years) and sex. MAIN OUTCOME MEASURES: Cerebrovascular risk factors and leukoaraiosis on CT scans of cases and controls; the odds ratio (OR) of having moderate to severe leukoaraiosis with higher levels of plasma tHcy and cerebrovascular risk factors such as age, sex, systolic blood pressure, smoking, diabetes mellitus, and apolipoprotein E epsilon4 genotype. RESULTS: Leukoaraiosis was more prevalent in AD cases. For a 5-micromol/L increase in tHcy levels, the OR for leukoaraiosis was 1.40 (95% confidence interval, 1.02-1.91) independent of other risk factors. The distribution pattern of leukoaraiosis was more marked in the deep white matter than in the periventricular area in individuals with elevated tHcy levels, particularly in patients with AD. CONCLUSIONS: Higher tHcy levels are an independent risk factor for moderate to severe leukoaraiosis in individuals with AD and of leukoaraiosis of the deep white matter in particular. The nature of the relationship between tHcy levels and leukoaraiosis in AD requires further longitudinal and intervention studies.
33
Clinical diagnosis of Alzheimer's disease
Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 28K citations · Full text
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Suzanne S. Mirra, Albert Heyman, Daniel W. McKeel et al. · Neurology · 1991 · 5.1K citations
15-year longitudinal study of blood pressure and dementia
Ingmar Skoog, Lennart Nilsson, G. Persson et al. · The Lancet · 1996 · 1.7K citations
Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease
Robert Clarke, A. David Smith, Kim A. Jobst et al. · Archives of Neurology · 1998 · 1.4K citations
Medicine, Geriatric Medicine, Aging +16